BVNKF — Bavarian Nordic A/S

BVNKF

HOLD / NEUTRALMeanRev

Composite

53.50

Technical

80.30

Fundamental

44.60

Rank

—

Price

33.66

Hurst

0.10

As of

Oct 5, 2026

Daily

Bavarian Nordic A/S

HealthcareBiotechnology

Bavarian Nordic A/S is a vaccine manufacturer based in Denmark that produces immunizations against various infectious diseases including smallpox, monkeypox, rabies, tick-borne encephalitis, cholera, and typhoid fever. The company markets these vaccines under multiple brand names and distributes them across North America, Europe, Asia, and other regions worldwide. The company is also conducting clinical trials on an experimental vaccine candidate for treating encephalitis viruses.

Market cap

$2.1B

P/E (trailing)

9.07

P/E (forward)

10.68

PEG ratio

—

Dividend yield

0.00%

Beta

0.98

52w range

27.56 – 37.22

Return on equity

+12.21%

Profit margin

+24.34%

Revenue growth

+23.20%

Earnings growth

+169.70%

Price history

1Y: 33.66 (-7.3%) · range 27.69–37.22

Cycle position

62/ 100 cycle scoreAPPROACHING EXIT

ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 12 · NOT READY · exit proximity 0

Conviction

27/ 100 · maturity 14%

VScore.0918

Buildup.3035

EMA entry setup.3812

Fundamentals.2345

Contributing sources

Source	Score	Last seen
event-calendar	0.726	Oct 5, 2026

Pattern & cluster

Pattern

NEUTRAL

Cluster

NEUTRAL

Forward returns

Not yet labeled — the study prices these as positions mature.